Skip to main content
Erschienen in: Intensive Care Medicine 8/2018

14.06.2018 | Editorial

Sepsis: who will shoot first? Pharma or diagnostics?

verfasst von: Julien Textoris, Anthony C. Gordon

Erschienen in: Intensive Care Medicine | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Excerpt

Sepsis has finally been acknowledged as a worldwide issue through a World Health Organization resolution in May 2017 [1, 2]. This was a year ago, but so far very few things have changed. There are ~ 27 million patients diagnosed with sepsis each year, and so we—the patients, their relatives and attending physicians—are in desperate need for good news. Although sepsis awareness has increased over the past 5 years, sepsis management still faces several urgent unmet medical needs. …
Literatur
1.
Zurück zum Zitat Seventieth World Health Assembly (2017) Improving the prevention, diagnosis and clinical management of sepsis. WHA70.7 Seventieth World Health Assembly (2017) Improving the prevention, diagnosis and clinical management of sepsis. WHA70.7
2.
Zurück zum Zitat Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S (2017) Recognizing sepsis as a global health priority—a WHO resolution. N Engl J Med 377:414–417CrossRefPubMed Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S (2017) Recognizing sepsis as a global health priority—a WHO resolution. N Engl J Med 377:414–417CrossRefPubMed
3.
Zurück zum Zitat Singer M (2016) The new sepsis consensus definitions (sepsis-3): the good, the not-so-bad, and the actually-quite-pretty. Intensive Care Med 42:2027–2029CrossRefPubMed Singer M (2016) The new sepsis consensus definitions (sepsis-3): the good, the not-so-bad, and the actually-quite-pretty. Intensive Care Med 42:2027–2029CrossRefPubMed
6.
Zurück zum Zitat Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS (2014) Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42:383–391CrossRefPubMedPubMedCentral Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS (2014) Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42:383–391CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866CrossRefPubMed Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866CrossRefPubMed
8.
Zurück zum Zitat Venet F, Rimmele T, Monneret G (2018) Management of sepsis-induced immunosuppression. Crit Care Clin 34:97–106CrossRefPubMed Venet F, Rimmele T, Monneret G (2018) Management of sepsis-induced immunosuppression. Crit Care Clin 34:97–106CrossRefPubMed
9.
Zurück zum Zitat Gouel-Cheron A, Allaouchiche B, Floccard B, Rimmele T, Monneret G (2015) Early daily mHLA-DR monitoring predicts forthcoming sepsis in severe trauma patients. Intensive Care Med 41:2229–2230CrossRefPubMed Gouel-Cheron A, Allaouchiche B, Floccard B, Rimmele T, Monneret G (2015) Early daily mHLA-DR monitoring predicts forthcoming sepsis in severe trauma patients. Intensive Care Med 41:2229–2230CrossRefPubMed
10.
Zurück zum Zitat Venet F, Tissot S, Debard AL, Faudot C, Crampe C, Pachot A, Monneret G (2007) Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med 35:1910–1917CrossRefPubMed Venet F, Tissot S, Debard AL, Faudot C, Crampe C, Pachot A, Monneret G (2007) Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med 35:1910–1917CrossRefPubMed
11.
Zurück zum Zitat Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G (2013) Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry B 84:59–62CrossRef Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G (2013) Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry B 84:59–62CrossRef
12.
Zurück zum Zitat Morris AC, Datta D, Shankar-Hari M, Stephen J, Weir CJ, Rennie J, Antonelli J, Bateman A, Warner N, Judge K, Keenan J, Wang A, Burpee T, Brown KA, Lewis SM, Mare T, Roy AI, Hulme G, Dimmick I, Rossi AG, Simpson AJ, Walsh TS (2018) Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med. https://doi.org/10.1007/s00134-018-5247-0 CrossRef Morris AC, Datta D, Shankar-Hari M, Stephen J, Weir CJ, Rennie J, Antonelli J, Bateman A, Warner N, Judge K, Keenan J, Wang A, Burpee T, Brown KA, Lewis SM, Mare T, Roy AI, Hulme G, Dimmick I, Rossi AG, Simpson AJ, Walsh TS (2018) Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med. https://​doi.​org/​10.​1007/​s00134-018-5247-0 CrossRef
13.
Zurück zum Zitat Rol ML, Venet F, Rimmele T, Moucadel V, Cortez P, Quemeneur L, Monneret G, the REALISM study group (2017) The REAnimation low immune status markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients. BMJ Open 7:e015734CrossRefPubMedPubMedCentral Rol ML, Venet F, Rimmele T, Moucadel V, Cortez P, Quemeneur L, Monneret G, the REALISM study group (2017) The REAnimation low immune status markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients. BMJ Open 7:e015734CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Peronnet E, Venet F, Maucort-Boulch D, Friggeri A, Cour M, Argaud L, Lepape A, the MIP Réa study group (2017) Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study. Intensive Care Med 43:1013–1020CrossRefPubMedPubMedCentral Peronnet E, Venet F, Maucort-Boulch D, Friggeri A, Cour M, Argaud L, Lepape A, the MIP Réa study group (2017) Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study. Intensive Care Med 43:1013–1020CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, Knight JC (2016) Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med 4:259–271CrossRefPubMedPubMedCentral Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, Knight JC (2016) Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med 4:259–271CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Park JW, Liu MC, Yee D, Yau C, van’t Veer LJ, Symmans WF, Berry DA, I-SPY Investigators (2016) Adaptive randomization of neratinib in early breast cancer. N Engl J Med 375:11–22CrossRefPubMedPubMedCentral Park JW, Liu MC, Yee D, Yau C, van’t Veer LJ, Symmans WF, Berry DA, I-SPY Investigators (2016) Adaptive randomization of neratinib in early breast cancer. N Engl J Med 375:11–22CrossRefPubMedPubMedCentral
Metadaten
Titel
Sepsis: who will shoot first? Pharma or diagnostics?
verfasst von
Julien Textoris
Anthony C. Gordon
Publikationsdatum
14.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 8/2018
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-018-5234-5

Weitere Artikel der Ausgabe 8/2018

Intensive Care Medicine 8/2018 Zur Ausgabe

Imaging in Intensive Care Medicine

An acute dyspnea

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.